TAMPA, Fla. & NEW YORK--(BUSINESS WIRE)--UTEK Corporation (AMEX:UTK) (LSE-AIM:UTK), an open innovation company focused on technology transfer, and NeoStem, Inc. (AMEX:NBS), a leading-edge biotechnology company capitalizing on breakthroughs in the burgeoning field of adult stem cell therapeutics, are pleased to announce that NeoStem, Inc. has acquired Stem Cell Technologies, Inc., a wholly owned subsidiary of UTEK, in a stock for stock transaction.
